84
Participants
Start Date
May 31, 2008
Primary Completion Date
October 31, 2008
Study Completion Date
November 30, 2008
Adipiplon
bilayer tablets 6 mg
Placebo
Placebo
Ambien CR
Ambien CR 12.5 mg
Adipiplon
bilayer tablets 9 mg
Clinilabs, Inc., New York
Neurotrials Research, Inc, Atlanta
Broward Research Group, Pembroke Pines
Miami Research Associates, South Miami
Tri-State Sleep Disorders Center, Cincinnati
Sleep and Behavior Medicine Institute, Vernon Hills
St. Luke's Hospital Sleep Medicine and Research Center, Chesterfield
Vince & Associates Clinical Research, Overland Park
Lynn Health Science Institute, Oklahoma City
Lead Sponsor
Neurogen Corporation
INDUSTRY